These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Suppression of angiogenic response in local vein wall is associated with reduced thrombus resolution. Evans CE; Grover SP; Saha P; Humphries J; Kim JW; Modarai B; Smith A Thromb Res; 2014 Sep; 134(3):682-5. PubMed ID: 25042562 [TBL] [Abstract][Full Text] [Related]
24. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Henke PK; Varga A; De S; Deatrick CB; Eliason J; Arenberg DA; Sukheepod P; Thanaporn P; Kunkel SL; Upchurch GR; Wakefield TW Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1130-7. PubMed ID: 15105284 [TBL] [Abstract][Full Text] [Related]
25. Upregulation of hypoxia-inducible factor 1 alpha in local vein wall is associated with enhanced venous thrombus resolution. Evans CE; Humphries J; Waltham M; Saha P; Mattock K; Patel A; Ahmad A; Wadoodi A; Modarai B; Burnand K; Smith A Thromb Res; 2011 Oct; 128(4):346-51. PubMed ID: 21621825 [TBL] [Abstract][Full Text] [Related]
27. Interleukin-6: a potential target for post-thrombotic syndrome. Wojcik BM; Wrobleski SK; Hawley AE; Wakefield TW; Myers DD; Diaz JA Ann Vasc Surg; 2011 Feb; 25(2):229-39. PubMed ID: 21131172 [TBL] [Abstract][Full Text] [Related]
28. Role and mechanism of tissue plasminogen activator in venous wall fibrosis remodeling after deep venous thrombosis via the glycogen synthase kinase-3 beta signaling pathway. Yin M; Tian S; Huang X; Huang Y; Jiang M J Surg Res; 2013 Oct; 184(2):1182-95. PubMed ID: 23632004 [TBL] [Abstract][Full Text] [Related]
29. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism. Sood V; Luke CE; Deatrick KB; Baldwin J; Miller EM; Elfline M; Upchurch GR; Wakefield TW; Henke PK Thromb Haemost; 2010 Dec; 104(6):1174-83. PubMed ID: 20886179 [TBL] [Abstract][Full Text] [Related]
33. Modulation of interleukin-6 and its effect on late vein wall injury in a stasis mouse model of deep vein thrombosis. Dowling AR; Luke CE; Cai Q; Pellerito AM; Obi AT; Henke PK JVS Vasc Sci; 2022; 3():246-255. PubMed ID: 35647566 [TBL] [Abstract][Full Text] [Related]
34. Circulating and vein wall P-selectin promote venous thrombogenesis during aging in a rodent model. Culmer DL; Diaz JA; Hawley AE; Jackson TO; Shuster KA; Sigler RE; Wakefield TW; Myers DD Thromb Res; 2013 Jan; 131(1):42-8. PubMed ID: 23174624 [TBL] [Abstract][Full Text] [Related]
35. Incomplete resolution of deep vein thrombosis under reduced flow conditions. Cooley BC; Chen CY; Hess R; Schmeling G Thromb Res; 2013 Jan; 131(1):55-8. PubMed ID: 22285299 [TBL] [Abstract][Full Text] [Related]
36. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. Myers DD; Henke PK; Bedard PW; Wrobleski SK; Kaila N; Shaw G; Meier TR; Hawley AE; Schaub RG; Wakefield TW J Vasc Surg; 2006 Sep; 44(3):625-32. PubMed ID: 16950445 [TBL] [Abstract][Full Text] [Related]
38. von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced Obesity. Michels A; Dwyer CN; Mewburn J; Nesbitt K; Kawecki C; Lenting P; Swystun LL; Lillicrap D Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2860-2874. PubMed ID: 32967458 [TBL] [Abstract][Full Text] [Related]
39. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis. Payne H; Ponomaryov T; Watson SP; Brill A Blood; 2017 Apr; 129(14):2013-2020. PubMed ID: 28104688 [TBL] [Abstract][Full Text] [Related]
40. Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice. El-Sayed OM; Dewyer NA; Luke CE; Elfline M; Laser A; Hogaboam C; Kunkel SL; Henke PK J Vasc Surg; 2016 Nov; 64(5):1450-1458.e1. PubMed ID: 26482993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]